As monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC) who are progression-free following platinum-based chemotherapy
In combination with axitinib is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).
No medicines have been found.
